Disclosure under Regulation 30A of SEBI (Listing Obligation and Disclosure Requirement)Regulations 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has informed BSE that it received a warning letter from SEBI dated 25 July 2025. The letter was issued because the company did not properly disclose the intimation for extension of the annual report filing deadline nor submit the extension letter from the Registrar of Companies (ROC) Delhi to the stock exchange. SEBI has cautioned the company to avoid such lapses in future, ensure timely and accurate disclosure, and warned that further non-compliance may attract disciplinary action. The letter must be placed before the Board of Directors at the next board meeting. The company has stated it is taking steps to strengthen its internal compliance framework.
This is a regulatory caution rather than a financial penalty or enforcement action, so the immediate financial impact on shareholders is limited. However, it flags weak compliance practices, and any repeated lapses going forward could invite stricter SEBI action, which is a minor governance risk to monitor.